42 results
Page 2 of 3
8-K
EX-2.1
qlh0m k8ppy0h77zmm2q
29 Mar 21
Tempest and Millendo Announce Proposed Merger Agreement
7:29am
425
EX-2.1
7cywfpdswa704j1qv
29 Mar 21
Business combination disclosure
7:27am
424B5
pwb7vufb3r4tay7w4wq
5 Dec 19
Prospectus supplement for primary offering
4:06pm
424B5
eyga7
4 Dec 19
Prospectus supplement for primary offering
4:12pm
DEFM14A
z9m21
6 Nov 18
Proxy related to merger
12:00am
424B3
6sd mb5uod2bj
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
9g95 lf1gbrh
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-2.1
por3up4nv9gush48
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.1
fqapjh6bau nmb9
9 Aug 18
Business combination disclosure
5:17pm